Grupo Espanol de Investigacion en Sarcomas   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Madrid Spain (1994)

Organization Overview

First Clinical Trial
2004
NCT00103168
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Grupo Español de Investigacion en Sarcomas | Grupo Espanol de Investigacion en Sarcomas